New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
08:41 EDTAUO, FL, SONC, LLY, FINL, FOLD, LULU, ARAYOn The Fly: Pre-market Movers
HIGHER AFTER GUIDANCE: Eli Lilly (LLY), up 1.7%... ALSO HIGHER: Amicus Theraputics (FOLD), up 8.5% after announcing results from Phase 2 study... AU Optronics (AUO), up 4.7% after DigiTimes said company asked to join Amazon supply chain... LOWER AFTER EARNINGS/GUIDANCE: Finish Line (FINL), down 7%... Sonic (SONC), down 5%... Accuray (ARAY), down 25.5%... ALSO LOWER: Foot Locker (FL), down 2% after disappointing results, guidance of peer Finish Line... lululemon (LULU), down 3.9% after downgrade to Neutral at Credit Suisse.
News For FINL;FL;LULU;LLY;AUO;FOLD;SONC;ARAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
08:53 EDTLLYNon-profit gives lukewarm review to MannKind inhaled insulin, TheStreet says
Subscribe for More Information
08:39 EDTFLFoot Locker fundamentals solid but negative sentiment weighs, says UBS
Subscribe for More Information
08:11 EDTSONCSonic reports Q2 SSS up approximately 11.5%
Subscribe for More Information
07:31 EDTARAYAccuray announces first patient treatment using CyberKnife M6 completed
Accuray announced that the first patient treatment has been completed using the CyberKnife M6 System with the InCise Multileaf Collimator. The treatment was administered as a multidisciplinary effort between Dr. Steven Burton from the Department of Radiation Oncology and Dr. Johnathan Engh from the Department of Neurosurgery at UPMC in Pittsburgh, Pennsylvania. UPMC was one of the InCise MLC evaluation sites working in collaboration with Accuray.
February 24, 2015
08:33 EDTFOLDArgos Therapeutics hires Joan Winterbottom as Chief Human Resources Officer
Argos Therapeutics (ARGS) announced that Joan Winterbottom will join the company as chief human resources officer. Winterbottom most recently served as senior vice president of human resources at Amicus Therapeutics (FOLD).
06:34 EDTLLYEli Lilly CEO states company is not for sale, Financial Times says
Subscribe for More Information
February 23, 2015
08:31 EDTLLYEli Lilly announces delay in submission of basal insulin peglispro beyond Q1
Subscribe for More Information
07:22 EDTFOLDSunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
07:06 EDTLLYEli Lilly and Incyte announces positive results for baricitinib
Subscribe for More Information
February 20, 2015
07:14 EDTLULUOppenheimer to hold a tour
Subscribe for More Information
February 19, 2015
08:04 EDTLLYEli Lilly extends Evacetrapib Phase 3 trial by six months
Subscribe for More Information
February 18, 2015
16:41 EDTFLFoot Locker approves $220M capital expenditure program for 2015
Subscribe for More Information
16:39 EDTFLFoot Locker raises dividend 14% to 25c, approves $1B share buyback
Foot Locker announced that its board authorized capital allocation initiatives that "simultaneously provide meaningful returns to shareholders and maintain a significant investment in its business operations." The board declared a quarterly cash dividend on the company's common stock of 25c per share, which will be payable on May 1 to shareholders of record on April 17. This dividend declaration represents a 14% increase over the company's previous quarterly per-share amount. The board also approved a new 3-year, $1B common share repurchase program extending through January 2018, replacing the company's previous $600M program. The company spent $305M under the previous program in 2014, and as of yesterday had substantially completed the full program amount, Foot Locker said.
February 17, 2015
18:43 EDTLULUApparel stocks lower after Perry Ellis warns of West Coast port disruption
Subscribe for More Information
13:08 EDTARAYAccuray licenses validate competitiveness, says Brean Capital
Subscribe for More Information
13:04 EDTARAYAccuray says 16 hospitals in China awarded class A user licenses
Accuray announced earlier today that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission. TomoTherapy System licenses were received by 12 hospitals and CyberKnife System licenses were received by four hospitals. Of the 16 licenses just issued, Accuray believes that six licenses will allow orders already in backlog to be recognized as revenue in the near future and 10 licenses are expected to lead to new system orders entered into backlog in the coming months. In total, between 2013 and year to date 2015, the NHFPC has released 32 of its planned 60 licenses.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use